Prevalence of Depression in Gynecologic and Breast Cancer Patients

Authors

  • Heather Dorich University of Rhode Island College of Pharmacy
  • Jayne Pawasauskas University of Rhode Island College of Pharmacy
  • Britny Rogala University of Rhode Island College of Pharmacy
  • Kate Lally Harvard Medical School, Dana Farber Cancer Institute

DOI:

https://doi.org/10.47611/jsr.v9i1.650

Keywords:

Depression, Palliative care, Gynecology, Cancer

Abstract

Objective

Depression has historically been an underdiagnosed and undertreated condition with a large impact on patient quality of life. Screening and diagnosis of depression may differ for various reasons, making proper diagnosis and treatment difficult.

Methods

In this retrospective cohort study, we analyzed the associations between the prevalence of depression and patient-specific factors in gynecologic and breast cancer patients who had received a palliative care consult. This study was conducted in a single institution that specializes in women and infant care. The primary objective was to quantify the prevalence of depression among palliative care patients. The secondary objective was to determine patient specific factors associated with a diagnosis of depression.

Results

Over the course of the one year inclusion period, a total of 73 patients met inclusion criteria. The prevalence of depression in this study was found to be 54.8%. A diagnosis of anxiety was associated with the presence of depression (77.5% vs 25%, p < 0. 0001). Cancer of the fallopian tube was also independently associated with depression (12. 5% vs 0, p = 0. 44).

Conclusion

The prevalence of depression for palliative care patients, specifically for patients with gynecologic and breast malignancies, in this study was higher than estimates of depression prevalence for the general population. The results of this study may indicate that a greater awareness of the need for screening and treatment of depression is necessary in this population, in order to properly diagnose and treat patients with depression.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biographies

Heather Dorich, University of Rhode Island College of Pharmacy

Student

Jayne Pawasauskas, University of Rhode Island College of Pharmacy

Clinical Professor, Department of Pharmacy Practice

Britny Rogala, University of Rhode Island College of Pharmacy

Clinical Assistant Professor, Department of Pharmacy Practice

Kate Lally, Harvard Medical School, Dana Farber Cancer Institute

Department of Psychosocial Oncology and Palliative Care

References or Bibliography

Friedlander, M. L., Stockler, M., O'Connell, R., Voysey, M., Oza, A., Gillies, K…Symptom Benefit Study Group (2014). Symptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the gynecologic cancer intergroup symptom benefit study. Inter-national journal of gynecological cancer, 24(5), 857-64. doi: 10.1097/IGC.0000000000000147.

World Health Organization (2018). Palliative Care. Retrieved from: http://www.who.int/en/news-room/fact-sheets/detail/palliative-care

Hotopf, M., Chidgey, J., Addington-Hall, J., & Ly, K.L. (2002). Depression in advanced disease: a system-atic review Part 1. Prevalence and case finding. Palliative Medicine, 16(2), 81-97.

Mitchell, A.J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., & Meader, N. (2012). Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. The Lancet. Oncology, 12(2), 160-74. doi: 10.1016/S1470-2045(11)70002-X.

Krebber, A.M., Buffart, L.M., Kleijn, G., Riepma, I.C., de Bree, R., Leemans, C.R… Verdonck-de Leeuw, I.M. (2014). Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psycho-oncology, 23(2),121-30. doi: 10.1002/pon.3409.

National Institute of Mental Health (2018). Major Depression. Retrieved from: https://www.nimh.nih.gov/health/statistics/major-depression.shtml.

Newport, D.J., & Nemeroff, C.B. (1998). Assessment and treatment of depression in the cancer patient. Journal of Psychosomatic Research, 45(3),215-37.

Cassedy, H.F., Tucker, C., Hynan, L.S., Phillips, R., Adams, C., Zimmerman, M.R…. Stringer, C.A. (2018). Frequency of psychological distress in gynecologic cancer patients seen in a large urban medical center. Pro-ceedings (Baylor University. Medical Center),31,161-164. doi: 10.1080/08998280.2018.1440857.

Klügel, S., Lücke, C., Meta, A., Schild-Suhren, M., Malik, E., Philipsen, A., & Muller, H. H. (2017). Con-comitant psychiatric symptoms and impaired quality of life in women with cervical cancer: a critical review. International Journal of Women’s Health, 9,795-805. doi: 10.2147/IJWH.S143368.

Brown, L.F., Kroenke, K., Theobald, D.E., Wu, J., & Tu, W. (2010). The association of depression and anxiety with health-related quality of life in cancer patients with depression and/or pain. Psycho-oncology, 19(7),734-41. doi: 10.1002/pon.1627.

Alacacioglu, A., Yavuzsen, T., Dirioz, M., & Yilmaz, U. (2009). Quality of life, anxiety and depression in Turkish breast cancer patients and in their husbands. Medical Oncology, 26(4),415-9. doi: 10.1007/s12032-008-9138-z.

Caplette-Gingras, A., & Savard, J. (2008). Depression in women with metastatic breast cancer: a review of the literature. Palliative & Supportive Care,6(4),377-87. doi: 10.1017/S1478951508000606.

Kroenke, K., Theobald, D., Wu, J., Loza, J.K., Carpenter, J.S., & Tu, W. (2010). The association of depres-sion and pain with health-related quality of life, disability, and health care use in cancer patients. Journal of Pain and Symptom Management, 40(3),327-41. doi: 10.1016/j.jpainsymman.2009.12.023.

Jia, H., Zack, M.M., Thompson, W.W., Crosby, A.E., & Gottesman, I.I. (2015). Impact of depression on quality-adjusted life expectancy (QALE) directly as well as indirectly through suicide. Social Psychiatry and Psychiatric Epidemiology, 50, 939-49. doi:10.1007/s00127-015-1019-0.

Greenberg, P.E., Fournier, A.A., Sisitsky, T., Pike, C.T., & Kessler, R.C. (2015). The economic burden of adults with major depressive disorder in the United States (2005 and 2010). The Journal of Clinical Psychia-try, 76(2), 155-62. doi: 10.4088/JCP.14m09298.

Fallowfield, L., Ratcliffe, D., Jenkins, V., & Saul J. (2001). Psychiatric morbidity and its recognition by doctors in patients with cancer. British Journal of Cancer, 84(8), 1011-5.

Thomas, R.A., Curley, B., Wen, S., Zhang, J., Abraham, J., & Moss, A.H. (2015). Palliative Care Training during Fellowship: A National Survey of U.S. Hematology and Oncology Fellows. Journal of Palliative Medi-cine, 18(9), 747-51. doi: 10.1089/jpm.2015.0035.

Holland, J.C., Deshields, T.L., Andersen, B., Braun, I., Breitbart, W.S., Brewer, B.W., et al. Distress Man-agement. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Version 2.2018.

Published

2020-10-31

How to Cite

Dorich, H., Pawasauskas, J., Rogala, B., & Lally, K. (2020). Prevalence of Depression in Gynecologic and Breast Cancer Patients. Journal of Student Research, 9(1). https://doi.org/10.47611/jsr.v9i1.650

Issue

Section

Research Articles